Dr. Reddy's Laboratories is set to attract investor attention after acquiring the India trademarks for specialty brands Progynova® and Cyclo-Progynova® from Mercury Pharma Group Limited for USD 32.15 ...
Dr Reddy's Laboratories has forayed into hormone replacement therapy segment by acquiring trademarks of specialty brands, Progynova and Cyclo-Progynova and related assets, for India from ...
On Wednesday, shares of Dr Reddy's slipped 0.32 per cent to settle at Rs 1280.85, down from its previous close of Rs 1285 apiece on the BSE.
Stocks like Dr Reddys Laboratories, Hindustan Unilever, Zydus Lifesciences, NCC, Pace Digitek, TVS Motor Company, Jindal Saw, and Cochin Shipyard will be in focus on.
Lowering tariffs could be an effective way for the Trump administration to address voters’ cost-of-living concerns, even if actual price trends reflect a more complex set of drivers.
The 'frog' poison that killed Navalny was hard to hide and likely made in a high-end lab, according to a Belgian toxicologist.
Understanding the differences between biological safety cabinets and laminar flow cabinets helps ensure the correct level of containment.
A whistleblower has raised safety concerns about working inside Porton Down, which has a long history of conducting dangerous biochemical research.
The UK pharmaceutical market is estimated at nearly £1 billion within this category, and this agreement positions Tilray and CC Pharma to work with Smartway to accelerate access, improve supply ...
Invests £400 million to expand biomanufacturing and process development in the North East of England.
Plans for a £1bn expansion of the London Cancer Hub in Sutton have been granted planning consent, paving the way for one of ...
LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results